Cited by 77Parkinson's Disease Mechanisms and TreatmentsCardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic Control

The potential prognostic role of cardiovascular autonomic failure in α‐synucleinopathies

Fanciulli, A., Strano, S., Colosimo, C., Caltagirone, C., Spalletta, G., Pontieri, F. E.·2013·European Journal of Neurology

Abstract

Cardiovascular autonomic failure is the second most common dysautonomic feature of α-synucleinopathies and has significant impact on daily activities and quality of life. Here we provide a systematic review of cardiovascular autonomic failure in α-synucleinopathies, emphasizing its impact on cognitive functions and disease outcomes. Articles spanning the period between January 1985 and April 2012 were identified from the PubMed database using a keyword-based search. Epidemiological studies highlight the negative prognostic effect of cardiovascular autonomic failure on cardiovascular and cerebrovascular outcomes and overall mortality in all α-synucleinopathies. Altered cerebral perfusion, vascular pressure stress, and related disruption of the blood-brain barrier may also contribute to the white matter hyperintensities and cognitive dysfunction frequently found in patients affected by neurocardiovascular instability. These findings support the hypothesis that cardiovascular autonomic failure may play a negative prognostic role in α-synucleinopathies and suggest that precocious screening and therapeutic management of cardiovascular autonomic failure may positively impact disease course.

Integrity signals

Registry

Crossref · 10.1111/j.1468-1331.2012.03819.x

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • OH is frequently associated with a nocturnal 'non-dipping' or even 'reverse-dipping' BP pattern in patients with autonomic failure, with relevant therapeutic and prognostic implications.

    “There is strong evidence that OH is frequently associated with a nocturnal 'non-dipping' or even 'reverse-dipping' BP pattern in patients with autonomic failure, with relevant therapeutic and prognostic implications 140,148-151”

Cites

Flagged first, then by citations

1 of the 97 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Fanciulli, A., Strano, S., Colosimo, C., Caltagirone, C., Spalletta, G., & Pontieri, F. E.
Affiliations
  • Azienda Ospedaliera Sant'Andrea (IT)
  • Sapienza University of Rome (IT)
  • University of Rome Tor Vergata (IT)
  • Fondazione Santa Lucia (IT)
Corresponding author
Pontieri, F. E.
Venue
European Journal of Neurology
Publisher
Wiley
Published
2012-07-27
Volume
20
Issue
2
Pages
231-235
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W2172237510
Cited by
77
References
97
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 6 · 2017: 11 · 2016: 9 · 2015: 6 · 2014: 7 · 2013: 5
FWCI
0.81
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Funders
  • Pfizer
  • University of Cambridge
  • H. Lundbeck A/S
  • Ipsen
  • UCB Pharma
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Keywords
synucleinopathies, Parkinson's disease, multiple system atrophy, prognosis, mortality, cerebrovascular outcomes, cognitive impairment, cerebral perfusion, blood-brain barrier, white matter hyperintensities, autonomic dysfunction
MeSH terms
Brain, Cardiovascular System, Cognition Disorders, Fatigue, Humans, Hypotension, Orthostatic, Parkinson Disease, Prognosis, Disease Progression, Multiple System Atrophy, Neurodegenerative Diseases, Lewy Body Disease, alpha-Synuclein, Primary Dysautonomias, Pure Autonomic Failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review